Table 1 Participant characteristics. Number of participants (N = 40) is less than the total enrolled in study (N = 41) as one participant did not complete their post-exam survey
From: Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison study
Characteristic | Trial population, n (%) (N = 40) |
|---|---|
Age, mean (range) | 28.7 (21, 39) |
Race/Ethnicity | |
White | 26 (65%) |
Non-white, minority | 14 (35%) |
BMI, kg/m2, mean (range) | 23.4 (17.3, 29.6) |
BMI > 25 (overweight) | 11 (28%) |
Contraception method | |
Oral contraceptives | 8 (20%) |
IUD | 14 (35%) |
NuvaRing | 3 (8%) |
Implant | 1 (3%) |
None | 14 (35%) |
Menstrual interval | |
22–35 days | 26 (65%) |
> 35 days | 3 (8%) |
< 22 days | 2 (5%) |
“Unsure” | 9 (23%) |